investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Single Molecule Imaging
David Rueda
0 Collaborator(s)
Funding source
Medical Research Council (MRC)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
David Rueda
MRC Clinical Sciences Centre (MRC)
London, United Kingdom
Related projects
Judith R Rees
Participant Beliefs and Bias in a Randomized Controlled Trial
Colorectum
Ajit P Varki
Oligosaccharies of Normal and Malignant Cells
Colorectum
Breast
Ulrike Peters
Molecular Pathological Epidemiology of Colorectal Cancer
Colorectum
Jane C Figueiredo
Adding Hispanics to Ongoing GWAS in Colorectal Cancer
Colorectum
Pathology
Ruth E Patterson
Energetics & Breast Cancer: Obesity, Inflammation, Insulin Resistance & Risk
Breast
Clemence Pinel
The construction of the environment in epigenetics research - A social science exploration
Breast
Rachael Rigby
Suppressor of cytokine signaling 3 is a key regulator of intestinal epithelial homeostasis
Colorectum
Ross L Prentice
Nutrition and Physical Activity Assessment Study (NPAAS)
Colorectum
Breast
Ovary
Corpus uteri
Suzanne A Fuqua
Integration of Predictive Biomarkers of Hormone Resistance in Breast Cancer
Breast
